Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
Progression of Macular Ischemia Following Intravitreal Bevacizumab
Ophthalmic Surgery, Lasers and Imaging, 05/22/09
Sabet-Peyman EJ et al. - A 37-year-old woman with bilateral obliterative retinal vasculitis and macular ischemia received intravitreal bevacizumab for rapidly progressive neovascularization of the optic disc and vitreous hemorrhage in the left eye. One week after treatment, she presented with central scotoma and fluorescein angiography revealed increased parafoveal capillary dropout and progressive macular ischemia in the treated eye.
Related Articles
Associations between chronic glycosylated haemoglobin (HbA1c) level and macular volume in diabetes patients without macular oedema
Acta Ophthalmologica, 11/13/09
Relevance Score: 46%
Is multifocal ERG a reliable index of macular function after triamcinolone acetonide injection in diffuse diabetic macular edema
European Journal of Ophthalmology, 11/11/09
Relevance Score: 45%
Bevacizumab Improves Macular Edema
Review of Ophthalmology, 10/02/09
Relevance Score: 44%
Pegaptanib Sodium for Macular Edema Secondary to Branch Retinal Vein Occlusion
American Journal of Ophthalmology, 10/30/09
Relevance Score: 43%
Statin Use and the Incidence of Advanced Age-Related Macular Degeneration in the Complications of Age-Related Macular Degeneration Prevention Trial
Ophthalmology, 10/28/09
Relevance Score: 43%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
Clinical Interventions in Aging, 11/30/09
Pharmacological and environmental factors in primary angle-closure glaucoma
British Medical Bulletin, 11/25/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
Clinical Interventions in Aging, 11/30/09
Oral transmucosal fentanyl citrate: a novel analgesic agent for use in retinal photocoagulation
Retina, 11/25/09
A 1-Year Retrospective Review of Ranibizumab for Naive Nonsubfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration
Retina, 11/25/09
Article Search
Sponsor


See Latest Articles


